Bioteque Corporation (4107.TWO)
TWD 120.0
(-1.23%)
TWD 120.0
(-1.23%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.94 Billion TWD | -3.26% |
| 2022 | 2.01 Billion TWD | 10.12% |
| 2021 | 1.82 Billion TWD | -6.27% |
| 2020 | 1.94 Billion TWD | 4.77% |
| 2019 | 1.85 Billion TWD | 15.24% |
| 2018 | 1.61 Billion TWD | 13.57% |
| 2017 | 1.42 Billion TWD | 0.94% |
| 2016 | 1.4 Billion TWD | 11.71% |
| 2015 | 1.25 Billion TWD | 12.08% |
| 2014 | 1.12 Billion TWD | 17.31% |
| 2013 | 957.88 Million TWD | 13.72% |
| 2012 | 842.3 Million TWD | 10.78% |
| 2011 | 760.31 Million TWD | -7.46% |
| 2010 | 821.62 Million TWD | 5.33% |
| 2009 | 780.01 Million TWD | 19.11% |
| 2008 | 654.86 Million TWD | 16.93% |
| 2007 | 560.06 Million TWD | 13.87% |
| 2006 | 491.85 Million TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 518.75 Million TWD | 4.53% |
| 2024 Q1 | 496.26 Million TWD | -4.27% |
| 2023 Q1 | 455.93 Million TWD | -14.47% |
| 2023 Q2 | 472.25 Million TWD | 3.58% |
| 2023 FY | 1.94 Billion TWD | -3.26% |
| 2023 Q4 | 518.41 Million TWD | 4.08% |
| 2023 Q3 | 498.09 Million TWD | 5.47% |
| 2022 Q2 | 486.48 Million TWD | 4.16% |
| 2022 Q4 | 533.07 Million TWD | 1.8% |
| 2022 Q1 | 467.05 Million TWD | -3.58% |
| 2022 FY | 2.01 Billion TWD | 10.12% |
| 2022 Q3 | 523.65 Million TWD | 7.64% |
| 2021 Q4 | 484.4 Million TWD | 9.26% |
| 2021 Q1 | 456.99 Million TWD | -13.23% |
| 2021 FY | 1.82 Billion TWD | -6.27% |
| 2021 Q2 | 440.73 Million TWD | -3.56% |
| 2021 Q3 | 443.35 Million TWD | 0.6% |
| 2020 FY | 1.94 Billion TWD | 4.77% |
| 2020 Q1 | 440.47 Million TWD | -6.34% |
| 2020 Q4 | 526.68 Million TWD | 2.86% |
| 2020 Q3 | 512.01 Million TWD | 9.29% |
| 2020 Q2 | 468.48 Million TWD | 6.36% |
| 2019 FY | 1.85 Billion TWD | 15.24% |
| 2019 Q2 | 473.53 Million TWD | 7.45% |
| 2019 Q1 | 440.71 Million TWD | 5.46% |
| 2019 Q4 | 470.31 Million TWD | -0.85% |
| 2019 Q3 | 474.33 Million TWD | 0.17% |
| 2018 FY | 1.61 Billion TWD | 13.57% |
| 2018 Q3 | 411.53 Million TWD | 0.95% |
| 2018 Q4 | 417.89 Million TWD | 1.54% |
| 2018 Q1 | 375.9 Million TWD | -2.05% |
| 2018 Q2 | 407.67 Million TWD | 8.45% |
| 2017 Q4 | 383.77 Million TWD | 7.15% |
| 2017 Q1 | 329.99 Million TWD | -1.95% |
| 2017 Q3 | 358.16 Million TWD | 2.84% |
| 2017 FY | 1.42 Billion TWD | 0.94% |
| 2017 Q2 | 348.28 Million TWD | 5.54% |
| 2016 Q2 | 366.6 Million TWD | 4.58% |
| 2016 Q3 | 353.25 Million TWD | -3.64% |
| 2016 Q4 | 336.55 Million TWD | -4.73% |
| 2016 FY | 1.4 Billion TWD | 11.71% |
| 2016 Q1 | 350.54 Million TWD | 2.86% |
| 2015 FY | 1.25 Billion TWD | 12.08% |
| 2015 Q1 | 302.83 Million TWD | 0.28% |
| 2015 Q4 | 340.79 Million TWD | 11.87% |
| 2015 Q2 | 311.16 Million TWD | 2.75% |
| 2015 Q3 | 304.62 Million TWD | -2.1% |
| 2014 Q4 | 301.99 Million TWD | 3.86% |
| 2014 FY | 1.12 Billion TWD | 17.31% |
| 2014 Q3 | 290.77 Million TWD | 5.66% |
| 2014 Q2 | 275.19 Million TWD | 7.62% |
| 2014 Q1 | 255.71 Million TWD | 1.96% |
| 2013 Q4 | 250.79 Million TWD | 3.27% |
| 2013 FY | 957.88 Million TWD | 13.72% |
| 2013 Q1 | 223.95 Million TWD | 2.85% |
| 2013 Q2 | 240.26 Million TWD | 7.28% |
| 2013 Q3 | 242.86 Million TWD | 1.08% |
| 2012 Q2 | 198.51 Million TWD | -2.44% |
| 2012 Q1 | 203.48 Million TWD | 0.83% |
| 2012 Q3 | 222.55 Million TWD | 12.11% |
| 2012 FY | 842.3 Million TWD | 10.78% |
| 2012 Q4 | 217.74 Million TWD | -2.16% |
| 2011 Q2 | 186.25 Million TWD | 2.69% |
| 2011 Q1 | 181.38 Million TWD | -6.07% |
| 2011 FY | 760.31 Million TWD | -7.46% |
| 2011 Q3 | 190.85 Million TWD | 2.47% |
| 2011 Q4 | 201.82 Million TWD | 5.75% |
| 2010 Q4 | 193.09 Million TWD | -11.83% |
| 2010 Q3 | 219 Million TWD | 4.72% |
| 2010 Q2 | 209.12 Million TWD | 4.35% |
| 2010 Q1 | 200.4 Million TWD | 0.0% |
| 2010 FY | 821.62 Million TWD | 5.33% |
| 2009 FY | 780.01 Million TWD | 19.11% |
| 2008 FY | 654.86 Million TWD | 16.93% |
| 2007 FY | 560.06 Million TWD | 13.87% |
| 2006 FY | 491.85 Million TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 4.39 Billion TWD | 55.741% |
| Chi Sheng Pharma & Biotech Co., Ltd | 1.06 Billion TWD | -83.313% |
| Sunder Biomedical Tech. Co., Ltd. | 770.19 Million TWD | -152.496% |
| BenQ Medical Technology Corporation | 4.54 Billion TWD | 57.193% |
| Pacific Hospital Supply Co., Ltd | 2.32 Billion TWD | 16.184% |
| Unicon Optical Co., Ltd. | 845.67 Million TWD | -129.959% |
| Formosa Optical Technology Co.,Ltd. | 3.86 Billion TWD | 49.669% |
| Medeon Biodesign, Inc. | 196.26 Million TWD | -890.865% |
| Concord Medical Co., Ltd. | 833.2 Million TWD | -133.401% |
| Crystalvue Medical Corporation | 823.96 Million TWD | -136.018% |
| Perfect Medical Industry Co., Ltd. | 734.13 Million TWD | -164.898% |
| ICARES Medicus, Inc. | 605.45 Million TWD | -221.198% |
| Lagis Enterprise Co., Ltd. | 459.93 Million TWD | -322.824% |
| Amed Co., Ltd. | 763.82 Million TWD | -154.601% |